Artigos com autorizações de acesso público - John Paul FruehaufSaiba mais
1 artigo não disponível publicamente
Changes in tumor blood flow as measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) may predict activity of single agent bevacizumab in recurrent …
DM Chase, MW Sill, BJ Monk, MD Chambers, KM Darcy, ES Han, ...
Gynecologic Oncology 126 (3), 375-380, 2012
Autorizações: US National Institutes of Health
14 artigos disponíveis publicamente
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma
KB Kim, JA Sosman, JP Fruehauf, GP Linette, SN Markovic, ...
Journal of Clinical Oncology 30 (1), 34-41, 2012
Autorizações: US National Institutes of Health
Prediction of drug response in breast cancer using integrative experimental/computational modeling
HB Frieboes, ME Edgerton, JP Fruehauf, FRAJ Rose, LK Worrall, ...
Cancer research 69 (10), 4484-4492, 2009
Autorizações: US National Institutes of Health
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study
LM Randall, BJ Monk, KM Darcy, C Tian, RA Burger, SY Liao, WA Peters, ...
Gynecologic oncology 112 (3), 583-589, 2009
Autorizações: US National Institutes of Health
Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels
Y Tang, B Parmakhtiar, AR Simoneau, J Xie, J Fruehauf, M Lilly, X Zi
Neoplasia 13 (2), 108-119, 2011
Autorizações: US National Institutes of Health
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study
SY Liao, KM Darcy, LM Randall, C Tian, BJ Monk, RA Burger, ...
Gynecologic oncology 116 (3), 452-458, 2010
Autorizações: US National Institutes of Health
Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance
M Zhang, W Fu, S Prabhu, JC Moore, J Ko, JW Kim, BJ Druker, V Trapp, ...
Molecular and cellular biology, 2008
Autorizações: US National Institutes of Health
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer
ES Han, RA Burger, KM Darcy, MW Sill, LM Randall, D Chase, ...
Gynecologic oncology 119 (3), 484-490, 2010
Autorizações: US National Institutes of Health
Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis
DJ Lindner, Y Wu, R Haney, BS Jacobs, JP Fruehauf, R Tuthill, ...
Matrix biology 32 (2), 123-132, 2013
Autorizações: US National Institutes of Health
Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer
HS Tran Cao, M Bouvet, S Kaushal, A Keleman, E Romney, G Kim, ...
Molecular cancer therapeutics 9 (7), 2068-2078, 2010
Autorizações: US National Institutes of Health
A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer
E Zhuang, E Uchio, M Lilly, X Zi, JP Fruehauf
Biomedicine & Pharmacotherapy 143, 112226, 2021
Autorizações: US National Institutes of Health
Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma
Z Eroglu, KM Kong, JG Jakowatz, W Samlowski, JP Fruehauf
Cancer chemotherapy and pharmacology 68, 1081-1087, 2011
Autorizações: US National Institutes of Health
A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
Z Eroglu, JP Fruehauf
Cancer chemotherapy and pharmacology 72, 263-267, 2013
Autorizações: US National Institutes of Health
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case report
DS Finley, N Narula, VA Valera, MJ Merino, J Fruehauf, ML Wu, ...
Urologic Oncology: Seminars and Original Investigations 29 (1), 85-89, 2011
Autorizações: US National Institutes of Health
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study
LM Randall, BJ Monk, J Moon, R Parker, M Al-Ghazi, S Wilczynski, ...
Gynecologic oncology 119 (3), 417-421, 2010
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador